Table 3

Association of RF IgA with high attenuation areas and interstitial lung abnormalities on CT

RF IgA quartilePer cent difference (95% CI) in HAA per doubling of RF IgAp Value
<6.04 U/mL6.04–9 U/mL9.04–15.86 U/mL>15.86 U/mLp Value for trend
No. of subjects1969155415291684
HAA, cm3, median (IQR)116.6 (99.0 to 142.5)119.9 (101.7 to 143.0)123.6 (102.9 to 148.1)124.5 (105.2 to 149.2)
Per cent difference (95% CI) in HAA
 Unadjusted0 (Ref)1.99 (0.03 to 3.99)5.15 (3.11 to 7.22)6.26 (4.25 to 8.30)<0.0011.65 (1.10 to 2.21)<0.001
 Adjusted*0 (Ref)1.73 (0.15 to 3.33)2.18 (0.57 to 3.82)3.25 (1.65 to 4.88)<0.0010.95 (0.50 to 1.40)<0.001
  Never smoker0 (Ref)1.96 (−0.37 to 4.35)1.02 (−1.37 to 3.46)2.58 (0.12 to 5.09)0.090.55 (−0.17 to 1.29)0.14
  Ever smoker0 (Ref)1.59 (−0.53 to 3.76)3.46 (1.29 to 5.69)4.35 (2.23 to 6.52)0.0011.35 (0.78 to 1.92)<0.001
Prevalence ratio (95% CI) for ILA per doubling of RF IgA
No. of subjects747617516523
ILA prevalence, % (95% CI)9.6 (7.7 to 12.0)12.5 (10.1 to 15.3)13.6 (10.9 to 16.8)16.1 (13.2 to 19.5)
Prevalence ratio (95% CI) for ILA
 Unadjusted1 (Ref)1.29 (0.96 to 1.75)1.41 (1.03 to 1.92)1.67 (1.24 to 2.24)0.0011.15 (1.08 to 1.23)<0.001
 Adjusted†1 (Ref)1.24 (0.92 to 1.68)1.26 (0.93 to 1.71)1.42 (1.05 to 1.91)0.0381.11 (1.03 to 1.20)0.006
  Never smoker1 (Ref)0.96 (0.60 to 1.51)0.88 (0.55 to 1.40)1.15 (0.73 to 1.82)0.461.04 (0.88 to 1.23)0.68
  Ever smoker1 (Ref)1.49 (0.99 to 2.22)1.67 (1.11 to 2.52)1.62 (1.09 to 2.42)0.0011.14 (1.05 to 1.23)0.001
  • *Adjusted for age, sex, race, study site, BMI, waist circumference, pack-years of smoking, current smoking status, total volume of imaged lung, per cent emphysema and tube current.

  • †Adjusted for age, sex, race, pack-years of smoking and current smoking status.

  • p Value for interaction of RF IgA and smoking was 0.15 in the HAA analysis and 0.31 in the ILA analysis.

  • HAA, high attenuation areas; ILA, interstitial lung abnormalities; RF, rheumatoid factor.